JPRN-UMIN000024414
Completed
N/A
An exploratory biomarker study of immunecheckpoint inhibitors using tumor tissue and peripheral blood - A biomarker study of immunecheckpoint inhibitors
Conditionslung cancer, and melanoma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- lung cancer, and melanoma
- Sponsor
- Wakayama Medical University
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Retrospective Cohort Study of immune checkpoint inhibitorCancerJPRN-UMIN000044830Juntendo University Hospital700
Recruiting
N/A
Predictive biomarker study of immune checkpoint inhibitors in metastatic head and neck squamous cell carcinomaNeoplasmsKCT0007598ational Cancer Center50
Recruiting
N/A
Prospective immune biomarker identification trial for renal cell carcinoma treatment.Renal cell carcinomaJPRN-UMIN000047119Keio University, school of medicine100
Completed
N/A
Immunological monitoring and assessment of biomarkers predictive of clinical response to first-line treatment with bosutinib or imatinib in chronic phase chronic myeloid leukemiaChronic myeloid leukemiaCML10024324NL-OMON42791Vrije Universiteit Medisch Centrum5
Not Yet Recruiting
N/A
se of certain Immunological Markers in blood to detect infection in Neonates.CTRI/2012/05/002651BECTION DICKINSON AND COMPANY100